--- title: "Eczema sufferer finds treatment that allows her to continue working as hairstylist" url: https://newscentral.site/eczema-sufferer-finds-treatment-that-allows-her-to-continue-working/ language: en publisher: "News Central Site" section: "Style" published: 2026-10-15T14:10:00.000Z updated: 2026-10-18T17:36:56.584Z id: 60f617de-bdb8-4b81-879a-e85330919ee4 source: "Elle https://www.elle.com/beauty/makeup-skin-care/a73244659/this-young-hairstylist-refused-to-let-eczema-define-her/" attribution: "Link to https://newscentral.site/eczema-sufferer-finds-treatment-that-allows-her-to-continue-working/ and name News Central Site when you quote or summarize this story." --- # Eczema sufferer finds treatment that allows her to continue working as hairstylist A 22-year-old woman from Texas has found a way to manage her eczema despite the demands of her job as a hairstylist. A 22-year-old hairstylist from Bryan, Texas, has found a way to manage her eczema despite the demands of her job. At the Collective Hair Studio where she works, Alayna is exposed to water, shampoo, conditioner, and dye on a daily basis. Her skin condition would often flare up after just a few hours of work, causing painful dryness and discomfort. Her hands were particularly affected, becoming dry and sore from constant use with chemicals and heat styling tools. On her drive home from the salon, Alayna would find temporary relief by dragging her hands against the seams of her steering wheel. This was just one of the daily struggles she faced due to her eczema. It took years for Alayna to find a treatment that worked for her. She tried various options before discovering NEMLUVIO (nemolizumab-ilto), which has helped her manage her condition and continue working in her dream career. With this new found stability, Alayna wants to share her message with others who may be struggling. Alayna's eczema began to manifest itself during high school, when dry, red patches would appear on her cheeks and around her eyes. Initially, she attributed these symptoms to seasonal changes or stress but they persisted long after those triggers had passed. As Alayna's eczema symptoms persisted, they began to affect her daily life in more noticeable ways. Initially, she had attributed these issues to seasonal changes or stress, but it soon became clear that there was something more underlying. The flares of inflammation would come and go, with periods of relative calm in between. To manage her symptoms, Alayna turned to topical medications, which provided some relief until she started experiencing eczema patches on her fingers while attending college. The chemicals in the hair products she handled daily during her nine-month program seemed to trigger the condition. The onset of full-time work marked a significant escalation of Alayna's eczema symptoms. Her hands bore the brunt of it, cracking, bleeding, and swelling as she struggled to find effective treatments. Despite trying various remedies, none of them provided lasting relief, making her job increasingly difficult. Her daily routine became consumed by managing her eczema, with tasks like applying makeup or even touching her eyes becoming major challenges. The oozing patches made it impossible for her to wear makeup, and the constant scratching left her hands raw and inflamed. At night, Alayna would try to find some respite from her discomfort by slathering her hands in petroleum jelly or thick hand masks, then taping gloves around her wrists to keep them on while she slept. However, this makeshift solution often fell apart during the night, leaving her bed a greasy mess and her skin still inflamed when she woke up. After trying various topical treatments and a new medication that effectively cleared her skin externally, Alayna's dermatologist acknowledged that the internal itchy sensations persisted despite these efforts. The young hairstylist had already lost faith in the effectiveness of medical interventions, having stopped treatment after just two sessions due to lack of progress. However, she refused to give up and continued searching for a solution that would address the root cause of her eczema symptoms. This determination was likely driven by her deep-seated desire to overcome the condition and regain control over her daily life. She can now perform her daily tasks without worrying about her skin flaring up. This is a significant improvement from her past experiences when even simple activities like washing her hands or shampooing clients' hair would trigger an eczema flare-up. The ability to work through the day and sleep soundly at night has greatly enhanced her quality of life. She no longer needs to wear gloves and apply petroleum jelly as a protective measure, which was a constant reminder of her condition. This newfound freedom is a testament to her perseverance in finding effective treatment for eczema. Her progress has also boosted her confidence significantly. Her improved sleep patterns have contributed to this positive change, allowing her to feel more energized and motivated throughout the day. As she looks back on her journey, she emphasizes that it was the years of struggle that ultimately led her to discover a solution. She encourages others living with eczema not to lose hope in their search for relief. By advocating for themselves and exploring various treatment options, they may find the right care to manage their condition and regain control over their daily lives. Advancements in medical research have led to a deeper understanding of atopic dermatitis, also known as eczema, and its effects on patients' lives. Studies have shown that interleukin-31 signaling plays a crucial role in the condition, bridging the gap between immune cells, the nervous system, and epithelial tissues. Recent clinical trials have demonstrated the efficacy of nemolizumab in treating atopic dermatitis. The medication has been found to rapidly improve itch symptoms in patients with moderate-to-severe eczema, including those with prurigo nodularis. These results are based on phase 3 studies published in reputable medical journals. The safety and efficacy of nemolizumab have also been evaluated in an open-label extension study, which followed patients for up to two years. The findings suggest that the medication can provide sustained benefits for individuals with atopic dermatitis when used in combination with topical therapies. Data from clinical trials, such as the ARCADIA 1 and ARCADIA 2 studies, have also highlighted the potential of nemolizumab in treating moderate-to-severe eczema in adolescents and adults. Regulatory authorities have not yet established the safety and efficacy of nemolizumab in children under 12 years old who suffer from atopic dermatitis. Similarly, there is a lack of information on whether this treatment is suitable for adolescents with prurigo nodularis, as it has only been tested in individuals over 18 years old. As a precautionary measure, patients should disclose any medical conditions they may have to their healthcare provider before initiating nemolizumab therapy. --- Source: [Elle](https://www.elle.com/beauty/makeup-skin-care/a73244659/this-young-hairstylist-refused-to-let-eczema-define-her/) Published by News Central Site: https://newscentral.site/eczema-sufferer-finds-treatment-that-allows-her-to-continue-working/